Patent · US Active

Pyrazine derivatives

US9403808B2 · kind B2 · utility

6Cited by

1References

2Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Caterina Bissantz · Rixheim, FR
Baledi Dhurwasulu · Darsi, IN
Uwe Grether · Weil am Rhein, DE
Anindya Hazra · Sherghati, IN
Paul Hebeisen · Basel, CH
Stephan Roever · Inzlingen, DE
Mark Rogers-Evans · Bottmingen, CH

Key dates

Filing date	Oct 24, 2012
Grant date	Aug 2, 2016
Priority date	—
Expiry date	Nov 10, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a compound of formula (I)wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament. In particular, the compound may be used as a preferential agonist of Cannabinoid Receptor 2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.